谷歌Chrome浏览器插件
订阅小程序
在清言上使用

MYC and MXI1 protein expression: potential prognostic significance in women with breast cancer in China.

ONCOLOGY RESEARCH AND TREATMENT(2014)

引用 5|浏览21
暂无评分
摘要
Objective: To investigate the expression levels and the clinical significance of MYC and MXI1 proteins in breast cancer. Methods: The expression levels of MYC and MXI1 were detected by immunohistochemical assay in 166 cases of breast cancer; the relationships among MYC, MXI1 and the clinicopathological parameters were analyzed by chi(2) test. Univariate analysis and Cox's proportional hazards model were used to evaluate the prognostic significance of the 2 proteins. Results: 27.71% of the tumor specimens showed high staining intensity for MYC (high-expression group, HEG-MYC) and 22.89% showed high staining intensity for MXI1 (HEG-MXI1); the expression of 2 proteins was negatively correlated (r = -0.177 p = 0.022). The Kaplan-Meier method for survival analysis showed that patients of the MYC-HEG demonstrated a significantly worse disease-specific survival than those of the MYC-low-expression group (LEG) (chi(2) = 11.102, p = 0.001). However, patients of the MXI1-HEG had a significantly better disease-specific survival than those of the MXI1-LEG (chi(2) = 7.858, p = 0.005). Both univariate analysis and Cox's proportional hazards model indicated that MYC and MXI1 could be independent prognostic molecular markers. Conclusion: MYC-HEG and MXI1-LEG levels are associated with poor prognosis in patients with breast cancer, suggesting that they may be useful molecular markers in breast cancer prognosis prediction.
更多
查看译文
关键词
MYC,MXI1,Breast cancer,Immunohistochemistry
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要